| Index | Ligand Name | Structure | PDB code | Compound Potency nM |
| 1 | deo | Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid | 1ros | 1.7 |
| 2 | cgs | Crystal Structure Analysis of human Macrophage Elastase MMP-12 | 1jiz | 2 |
| 3 | cgs | Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases. | 2w0d | 2 |
| 4 | e37 | Human MMP12 in complex with L-glutamate motif inhibitor | 4efs | 2.5 |
| 5 | nhk | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(N-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide | 3nx7 | 7.88 |
| 6 | ngh | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH at 1.3 A resolution | 1rmz | 10 |
| 7 | z79 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-sulfonyl-glycine hydroxamate | 3lk8 | 19.7 |
| 8 | jt5 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(N-hydroxyethyl)biphenyl-4-ylsulfonamido)acetamide | 3n2v | 31 |
| 9 | hs5 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide | 3f18 | 39.5 |
| 10 | 576 | MMP12 complex with a beta hydroxy carboxylic acid | 2woa | 1150 |
| 11 | cp8 | Crystal Structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid | 1utt | 1e+005 |